Supriya Lifescience Ltd vs Vineet Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Supriya Lifescience Ltd is ₹ 694.5 as of 30 Apr 15:30 . The P/E Ratio of Supriya Lifescience Ltd changed from 26.1 on March 2022 to 31.4 on March 2025 . This represents a CAGR of 4.73% over 4 yearsThe P/E Ratio of Vineet Laboratories Ltd changed from 6.6 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 years The Market Cap of Supriya Lifescience Ltd changed from ₹ 3967 crore on March 2022 to ₹ 5903 crore on March 2025 . This represents a CAGR of 10.45% over 4 yearsThe Market Cap of Vineet Laboratories Ltd changed from ₹ 43.7 crore on March 2022 to ₹ 28.06 crore on March 2025 . This represents a CAGR of -10.48% over 4 years The revenue of Supriya Lifescience Ltd for the Dec '25 is ₹ 209.05 crore as compare to the Sep '25 revenue of ₹ 202.56 crore. This represent the growth of 3.2% The revenue of Vineet Laboratories Ltd for the Dec '25 is ₹ 15.7 crore as compare to the Sep '25 revenue of ₹ 17.43 crore. This represent the decline of -9.93% The ebitda of Supriya Lifescience Ltd for the Dec '25 is ₹ 74.24 crore as compare to the Sep '25 ebitda of ₹ 75.37 crore. This represent the decline of -1.5% The ebitda of Vineet Laboratories Ltd for the Dec '25 is ₹ 2.54 crore as compare to the Sep '25 ebitda of ₹ 3.18 crore. This represent the decline of -20.13% The net profit of Supriya Lifescience Ltd changed from ₹ 44.64 crore to ₹ 49.68 crore over 7 quarters. This represents a CAGR of 6.30% The net profit of Vineet Laboratories Ltd changed from ₹ -2.13 crore to ₹ 0.85 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Supriya Lifescience Ltd changed from 3.2 % on March 2021 to 4.28 % on March 2025 . This represents a CAGR of 5.99% over 5 yearsThe Dividend Payout of Vineet Laboratories Ltd changed from 13.89 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 years .

About Supriya Lifescience Ltd

Supriya Lifescience Limited was initially constituted on October 29, 1985, as a 'Partnership Firm under the name M/s Supriya Chemicals'.
The Partnership Firm was last re-constituted pursuant to a Partnership Deed dated November 30, 2007.
Upon the conversion of M/s Supriya Chemicals' the Partnership Firm into a Public Limited Company, the Company got incorporated as Supriya Lifescience Limited' vide certified on March 26, 2008 by the Registrar of Companies, Mumbai. The Company commenced operations in April, 2008.
It is engaged in manufacturing and export of active pharmaceutical ingredients (APIs).
The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients,with a focus on research and development.

About Vineet Laboratories Ltd

Vineet Laboratories Limited, formerly known as Ortin Laboratories Limited is a manufacturing company of intermediates useful for the manufacture of active pharmaceutical ingredients.
The Company was incorporated on 10 November 2016 and operates in the business of in the manufacture of Drug Intermediates & Bulk Dugs.
The name of the Company changed to Vineet Laboratories Limited, on account of demerger in December, 2020. The production unit located at Malkapur Village, Yadadri- Bhuvanagiri District in Telangana State, India, is a multipurpose facility well equipped with stainless steel and glass-lined reactors with total volume of 230KL, of different volumes to suit any batch size.
Special provisions are made to carry out reactions at very low temperature (up to -100°C).
The Company is also specialized in manufacturing and handling pyrophoric chemicals like n-Butyl Lithium.

FAQs for the comparison of Supriya Lifescience Ltd and Vineet Laboratories Ltd

Which company has a larger market capitalization, Supriya Lifescience Ltd or Vineet Laboratories Ltd?

Market cap of Supriya Lifescience Ltd is 5,589 Cr while Market cap of Vineet Laboratories Ltd is 73 Cr

What are the key factors driving the stock performance of Supriya Lifescience Ltd and Vineet Laboratories Ltd?

The stock performance of Supriya Lifescience Ltd and Vineet Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Supriya Lifescience Ltd and Vineet Laboratories Ltd?

As of May 4, 2026, the Supriya Lifescience Ltd stock price is INR ₹694.5. On the other hand, Vineet Laboratories Ltd stock price is INR ₹38.1.

How do dividend payouts of Supriya Lifescience Ltd and Vineet Laboratories Ltd compare?

To compare the dividend payouts of Supriya Lifescience Ltd and Vineet Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.